Ownership as of September 30, 2021. Ten largest shareholders.
NameSeries A sharesSeries B sharesShare capital %Voting rights %
ANNWALL & ROTHSCHILD INVESTMENTS AB377 736410 4787.0228.63
SIX SIS AG, W8IMY01 210 16110.788.27
FJÄRDE AP-FONDEN01 120 0009.987.66
SWEDBANK ROBUR NY TEKNIK BTI0551 8004.923.77
AMF AKTIEFOND SMÅBOLAG0501 5854.473.43
TREDJE AP-FONDEN0501 5794.473.43
ÅLANDSBANKEN ABP0328 0702.922.24
SKANDINAVISKA ENSKILDA BANKEN AB, W8IMY0325 1042.902.22
UNIONEN0322 1962.872.20
DANGOOR, DAVID0306 4212.732.10
Sub-total377 7365 577 39453.0563.96
Other shareholders05 271 05446.9536.04
Total377 73610 848 448100.00100.00
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 377,736 class A shares with 10 votes per share and 10,848,448 class B shares with one vote per share, in total 11,226,184 shares.